William P. Allan

799 total citations
20 papers, 683 citations indexed

About

William P. Allan is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, William P. Allan has authored 20 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in William P. Allan's work include Cancer therapeutics and mechanisms (14 papers), Lung Cancer Research Studies (4 papers) and Synthesis and biological activity (3 papers). William P. Allan is often cited by papers focused on Cancer therapeutics and mechanisms (14 papers), Lung Cancer Research Studies (4 papers) and Synthesis and biological activity (3 papers). William P. Allan collaborates with scholars based in United States, Canada and Australia. William P. Allan's co-authors include Jack C. Yalowich, Mark W. Perlin, Brian B. Hasinoff, Jessica L. Smith, Barry W. Duceman, Cheryl L. Fattman, M K Ritke, Sa Shen, Andrew M. Creighton and Shirley Y. Hill and has published in prestigious journals such as Biochemistry, Free Radical Biology and Medicine and Critical Care Medicine.

In The Last Decade

William P. Allan

20 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William P. Allan United States 13 512 180 130 89 71 20 683
Kenneth D. Bromberg United States 14 746 1.5× 46 0.3× 163 1.3× 80 0.9× 79 1.1× 17 926
Scott Cosmi United States 17 168 0.3× 115 0.6× 103 0.8× 82 0.9× 5 0.1× 23 582
Yusuke Kamada Japan 15 497 1.0× 47 0.3× 125 1.0× 59 0.7× 5 0.1× 23 634
Lorne J. Brandes Canada 17 358 0.7× 157 0.9× 115 0.9× 54 0.6× 17 0.2× 29 731
Joyce T. Coll United States 8 913 1.8× 31 0.2× 200 1.5× 98 1.1× 8 0.1× 11 1.1k
Rosanna Tedesco United States 13 345 0.7× 534 3.0× 107 0.8× 368 4.1× 69 1.0× 15 1.1k
V Vivat France 8 1.1k 2.1× 855 4.8× 101 0.8× 44 0.5× 42 0.6× 8 1.4k
J. Zimmer Germany 16 905 1.8× 243 1.4× 188 1.4× 43 0.5× 4 0.1× 28 1.1k
Israel Posner United States 12 281 0.5× 29 0.2× 138 1.1× 84 0.9× 5 0.1× 35 627
H. Koester Germany 8 368 0.7× 132 0.7× 50 0.4× 59 0.7× 4 0.1× 11 577

Countries citing papers authored by William P. Allan

Since Specialization
Citations

This map shows the geographic impact of William P. Allan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William P. Allan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William P. Allan more than expected).

Fields of papers citing papers by William P. Allan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William P. Allan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William P. Allan. The network helps show where William P. Allan may publish in the future.

Co-authorship network of co-authors of William P. Allan

This figure shows the co-authorship network connecting the top 25 collaborators of William P. Allan. A scholar is included among the top collaborators of William P. Allan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William P. Allan. William P. Allan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Perlin, Mark W., et al.. (2011). Validating TrueAllele® DNA Mixture Interpretation*,†. Journal of Forensic Sciences. 56(6). 1430–1447. 174 indexed citations
3.
Perlin, Mark W., et al.. (2010). Validating Trueallele® DNA Mixture Interpretation. SSRN Electronic Journal. 3 indexed citations
4.
Hill, Shirley Y., Sa Shen, Nicholas Zezza, et al.. (2004). A genome wide search for alcoholism susceptibility genes. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 128B(1). 102–113. 82 indexed citations
5.
Hasinoff, Brian B., et al.. (2001). The Catalytic DNA Topoisomerase II Inhibitor Dexrazoxane (ICRF-187) Induces Differentiation and Apoptosis in Human Leukemia K562 Cells. Molecular Pharmacology. 59(3). 453–461. 50 indexed citations
6.
Hasinoff, Brian B., et al.. (2001). The Catalytic DNA Topoisomerase II Inhibitor Dexrazoxane (ICRF-187) Induces Differentiation and Apoptosis in Human Leukemia K562 Cells. Molecular Pharmacology. 59(3). 453–461. 2 indexed citations
7.
Kurz, Ebba U., Steven E. Wilson, Brante P. Sampey, et al.. (2001). The histone deacetylase inhibitor sodium butyrate induces DNA topoisomerase II alpha expression and confers hypersensitivity to etoposide in human leukemic cell lines.. PubMed. 1(2). 121–31. 61 indexed citations
8.
9.
Yalowich, Jack C., Nikolai V. Gorbunov, Andrey V. Kozlov, William P. Allan, & Valerian E. Kagan. (1999). Mechanisms of Nitric Oxide Protection against tert-Butyl Hydroperoxide-Induced Cytotoxicity in iNOS-Transduced Human Erythroleukemia Cells. Biochemistry. 38(33). 10691–10698. 13 indexed citations
10.
Hasinoff, Brian B., Theodore I. Kuschak, Andrew M. Creighton, et al.. (1997). Characterization of a Chinese hamster ovary cell line with acquired resistance to the bisdioxopiperazine dexrazoxane (ICRF-187) catalytic inhibitor of topoisomerase II. Biochemical Pharmacology. 53(12). 1843–1853. 40 indexed citations
11.
Hasinoff, Brian B., et al.. (1997). Mitindomide Is a Catalytic Inhibitor of DNA Topoisomerase II That Acts at the Bisdioxopiperazine Binding Site. Molecular Pharmacology. 52(5). 839–845. 48 indexed citations
12.
Lazo, John S., et al.. (1997). Chemical synthesis and biological activity of a novel fluorescent etoposide derivative. Biochemical Pharmacology. 53(5). 715–722. 3 indexed citations
13.
Fattman, Cheryl L., William P. Allan, Brian B. Hasinoff, & Jack C. Yalowich. (1996). Collateral sensitivity to the bisdioxopiperazine dexrazoxane (ICRF-187) in etoposide (VP-16)-resistant human leukemia K562 cells. Biochemical Pharmacology. 52(4). 635–642. 38 indexed citations
14.
Yalowich, Jack C., Yulia Y. Tyurina, Vladimir A. Tyurin, William P. Allan, & Valerian E. Kagan. (1996). Reduction of phenoxyl radicals of the antitumour agent etoposide (VP-16) by glutathione and protein sulfhydryls in human leukaemia cells: Implications for cytotoxicity. Toxicology in Vitro. 10(1). 59–68. 8 indexed citations
15.
Ritke, M K, Nicole R. Murray, William P. Allan, Alan P. Fields, & Jack C. Yalowich. (1995). Hypophosphorylation of topoisomerase II in etoposide (VP-16)-resistant human leukemia K562 cells associated with reduced levels of beta II protein kinase C.. Molecular Pharmacology. 48(5). 798–805. 28 indexed citations
16.
Allan, William P., et al.. (1994). Increased c-jun/AP-1 levels in etoposide-resistant human leukemia K562 cells. Biochemical Pharmacology. 48(3). 525–533. 29 indexed citations
17.
Yalowich, Jack C., et al.. (1994). METALLOTHIONEIN (MT) REDUCES THE CYTOXICITY AND DNA DAMAGING EFFECTS OF NITRIC OXIDE (NO). Critical Care Medicine. 22(1). A221–A221. 1 indexed citations
18.
Ritke, M K, James M. Rusnak, J S Lazo, et al.. (1994). Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells.. Molecular Pharmacology. 46(4). 605–611. 54 indexed citations
19.
Ritke, M K, William P. Allan, Cheryl L. Fattman, Nuray Gündüz, & Jack C. Yalowich. (1994). Reduced phosphorylation of topoisomerase II in etoposide-resistant human leukemia K562 cells.. Molecular Pharmacology. 46(1). 58–66. 35 indexed citations
20.
Yalowich, Jack C., H. Gregg Claycamp, Detcho A. Stoyanovsky, et al.. (1993). Two faces of the phenolic antitumor drug etoposide (VP-16): Free radical enhancement of cytotoxicity and protection against free radical-induced DNA damage. Free Radical Biology and Medicine. 15(5). 493–493. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth D. Bromberg Breakdown of academic impact, for papers by Scott Cosmi Breakdown of academic impact, for papers by Yusuke Kamada Breakdown of academic impact, for papers by Lorne J. Brandes Breakdown of academic impact, for papers by Joyce T. Coll Breakdown of academic impact, for papers by Rosanna Tedesco Breakdown of academic impact, for papers by V Vivat Breakdown of academic impact, for papers by J. Zimmer Breakdown of academic impact, for papers by Israel Posner Breakdown of academic impact, for papers by H. Koester
Rankless by CCL
2026